Boston Scientific (NYSE: BSX) has launched Endura Weight Loss Solutions, alongside survey findings showing that many U.S. women are frustrated with their weight loss attempts and unaware of non-surgical options.
Boston Scientific released data from a national survey of 2,000 U.S. women ages 30 to 65. Among those who had tried to lose weight, the average number of attempts was seven. In most cases, women did not meet their goals. Approximately 41% reported being unhappy with their current weight. Of those, more than half are searching for new methods.
The survey also found that 40% of women think about weight loss on a daily basis. When asked about their motivations, most cited appearance and physical health, but mental well-being also played a role. Respondents were allowed to choose multiple reasons: 65% selected appearance, 63% physical health, 59% personal satisfaction and 59% self-esteem.
“At Boston Scientific, we’re advancing science in ways that make a real difference in people’s health,” said Dr. Brian Dunkin, chief medical officer of endoscopy at Boston Scientific. “Losing weight is personal – no single method is going to work for everyone. By introducing Endura Weight Loss Solutions we’re meeting people where they are. It’s a new name for a different kind of approach – one that is clinically supported and minimally invasive for those who may not want to undergo surgery or take weight loss medications long-term.”
Endura represents a category of endoscopic procedures, including endoscopic sleeve gastroplasty (ESG) and intragastric balloon placement using the Orbera Intragastric Balloon System. Neither method involves external incisions, and both reduce stomach space to help patients eat less and feel full longer.
During an ESG procedure, an endoscope is inserted through the mouth and guided into the stomach. Using the company’s OverStitch Endoscopic Suturing System, physicians can sew the stomach from the inside to reduce its capacity by 70% to 80%. Intragastric balloon placement involves filling a balloon in the stomach to about the size of a grapefruit. The balloon is removed after six months.
Both procedures are typically outpatient. Patients often return to routine activities within a few days. Clinical evidence has shown that the procedures support effective weight loss when paired with lifestyle changes such as diet and exercise.
Still, many women are unfamiliar with these options. Nearly half of the survey respondents who had tried to lose weight said they were unaware of endoscopic procedures. A third said they would consider one.
To support the launch, Boston Scientific is rolling out “Break Through,” a national media campaign aimed at raising awareness of minimally invasive weight loss options and addressing survey findings around mental and physical barriers to weight loss.
Boston Scientific’s Cat Jennings and Kristin LaRocca will share Boston Scientific’s formula for integrating acquired MedTech companies on a panel at DeviceTalks West, Oct. 15–16, 2025 in Santa Clara, California. Register at West.DeviceTalks.com.
